Closing Remarks

dc.contributor.authorGoodnow, Chrisen
dc.coverage.spatialChichesteren
dc.date.accessioned2025-12-31T21:42:06Z
dc.date.available2025-12-31T21:42:06Z
dc.date.issued2007en
dc.description.statusPeer-revieweden
dc.format.extent2en
dc.identifier.isbn9780470027554en
dc.identifier.isbn9780470062128en
dc.identifier.issn1528-2511en
dc.identifier.scopus55949084581en
dc.identifier.urihttps://hdl.handle.net/1885/733798317
dc.language.isoenen
dc.publisherJohn Wiley & Sons Ltd.en
dc.relation.ispartofDecoding the Genomic Control of Immune Reactionsen
dc.relation.ispartofseriesNovartis Foundation Symposiumen
dc.relation.ispartofseriesNovartis Foundation Symposium 281en
dc.rights© Novartis Foundation 2007en
dc.titleClosing Remarksen
dc.typeConference paperen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage209en
local.bibliographicCitation.startpage208en
local.contributor.affiliationGoodnow, Chris; John Curtin School of Medical Research, ANU College of Science and Medicine, The Australian National Universityen
local.identifier.ariespublicationU3488905xPUB8078en
local.identifier.doi10.1002/9780470062128.ch17en
local.identifier.pure41df39d7-83bc-4b84-bbe2-81c31be7b38een
local.identifier.urlhttps://www.scopus.com/pages/publications/55949084581en
local.type.statusPublisheden

Downloads